Instrument ushers in a new phase of biologic characterization, empowering scientists to analyze more samples and molecules to meet next-gen drug development challenges September 01, 2021 Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, presents the latest capillary electrophoresis solution, the BioPhase 8800 system. This is the only... Read more
WASHINGTON, Aug. 30, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today the completion of its acquisition of Aldevron. As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher’s Life Sciences segment. ABOUT DANAHER Danaher is a global science and technology innovator committed to helping its customers solve complex... Read more
WASHINGTON, Aug. 24, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced that, effective April 1, 2022, Georgeann F. Couchara will succeed Angela S. Lalor as Senior Vice President, Human Resources. At that time, Ms. Lalor will move to a part time, advisory role until her retirement in the first quarter of 2023. Ms. Couchara, currently Vice President,... Read more
Danaher Announces Passing of Former President & CEO, George M. Sherman WASHINGTON, Aug. 20, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that George M. Sherman, the Company’s President & Chief Executive Officer during the years 1990-2001, died earlier this week after an illness. Steven M. Rales, Danaher Chairman of the Board, commented: “All of us... Read more
The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process. July 29, 2021 Framingham, MA, USA and Basel, Switzerland — SCIEX, a global leader in life science analytical technologies, and Genedata, leading provider of biopharma enterprise software solutions, have entered into a strategic partnership to develop new software... Read more
WASHINGTON, July 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the second quarter 2021. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended July 2, 2021, net earnings were $1.7 billion, or $2.28 per diluted common share which represents an 84.0% year-over-year... Read more
WASHINGTON, June 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more
WASHINGTON, June 17, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance of commercial paper. Founded in 1998... Read more
WASHINGTON, May 27, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Jefferies Healthcare Conference on Wednesday, June 2, 2021 at 1:00 p.m. ET. The video will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a global science and technology innovator... Read more
Danaher Announces Appointment of A. Shane Sanders to Danaher Board WASHINGTON, May 13, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has appointed A. Shane Sanders to its Board of Directors and to its Audit Committee. This addition expands the size of Danaher’s Board from twelve to thirteen members. Mr. Sanders is currently Senior... Read more